Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.

Munoz DM, Cassiani PJ, Li L, Billy E, Korn JM, Jones MD, Golji J, Ruddy DA, Yu K, McAllister G, DeWeck A, Abramowski D, Wan J, Shirley MD, Neshat SY, Rakiec D, de Beaumont R, Weber O, Kauffmann A, McDonald ER 3rd, Keen N, Hofmann F, Sellers WR, Schmelzle T, Stegmeier F, Schlabach MR.

Cancer Discov. 2016 Aug;6(8):900-13. doi: 10.1158/2159-8290.CD-16-0178. Epub 2016 Jun 3.

2.

Analysis of real-time serotonin (5-HT) availability during experimental colitis in mouse.

Bertrand PP, Barajas-Espinosa A, Neshat S, Bertrand RL, Lomax AE.

Am J Physiol Gastrointest Liver Physiol. 2010 Mar;298(3):G446-55. doi: 10.1152/ajpgi.00318.2009. Epub 2009 Dec 17.

3.

Tumour necrosis factor alpha activates nuclear factor kappaB signalling to reduce N-type voltage-gated Ca2+ current in postganglionic sympathetic neurons.

Motagally MA, Lukewich MK, Chisholm SP, Neshat S, Lomax AE.

J Physiol. 2009 Jun 1;587(Pt 11):2623-34. doi: 10.1113/jphysiol.2009.172312. Epub 2009 Apr 29.

4.

Inhibition of sympathetic N-type voltage-gated Ca2+ current underlies the reduction in norepinephrine release during colitis.

Motagally MA, Neshat S, Lomax AE.

Am J Physiol Gastrointest Liver Physiol. 2009 May;296(5):G1077-84. doi: 10.1152/ajpgi.00006.2009. Epub 2009 Mar 5.

5.

Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39.

Neshat S, deVries M, Barajas-Espinosa AR, Skeith L, Chisholm SP, Lomax AE.

Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G399-405. doi: 10.1152/ajpgi.90450.2008. Epub 2008 Dec 12.

6.

Sympathetic vasoconstrictor regulation of mouse colonic submucosal arterioles is altered in experimental colitis.

Lomax AE, O'Reilly M, Neshat S, Vanner SJ.

J Physiol. 2007 Sep 1;583(Pt 2):719-30. Epub 2007 Jul 5.

7.
8.

Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa.

Tam VH, Schilling AN, Neshat S, Poole K, Melnick DA, Coyle EA.

Antimicrob Agents Chemother. 2005 Dec;49(12):4920-7.

11.

Conservation of the multidrug resistance efflux gene oprM in Pseudomonas aeruginosa.

Bianco N, Neshat S, Poole K.

Antimicrob Agents Chemother. 1997 Apr;41(4):853-6.

12.

Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression.

Poole K, Tetro K, Zhao Q, Neshat S, Heinrichs DE, Bianco N.

Antimicrob Agents Chemother. 1996 Sep;40(9):2021-8.

13.
14.

Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa.

Poole K, Gotoh N, Tsujimoto H, Zhao Q, Wada A, Yamasaki T, Neshat S, Yamagishi J, Li XZ, Nishino T.

Mol Microbiol. 1996 Aug;21(4):713-24.

PMID:
8878035
15.

The Pseudomonas aeruginosa tonB gene encodes a novel TonB protein.

Poole K, Zhao Q, Neshat S, Heinrichs DE, Dean CR.

Microbiology. 1996 Jun;142 ( Pt 6):1449-58.

PMID:
8704984
16.

Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.

Poole K, Krebes K, McNally C, Neshat S.

J Bacteriol. 1993 Nov;175(22):7363-72.

18.

Cloning and nucleotide sequence analysis of the ferripyoverdine receptor gene fpvA of Pseudomonas aeruginosa.

Poole K, Neshat S, Krebes K, Heinrichs DE.

J Bacteriol. 1993 Aug;175(15):4597-604.

19.
20.

Enterobactin-mediated iron transport in Pseudomonas aeruginosa.

Poole K, Young L, Neshat S.

J Bacteriol. 1990 Dec;172(12):6991-6.

Supplemental Content

Loading ...
Support Center